Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDMG.L Regulatory News (MDMG)

  • There is currently no data for MDMG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own GDRs

7 Jul 2014 11:47

RNS Number : 6108L
MD Medical Group Investments PLC
07 July 2014
 

Transaction in own GDRs

07 July 2014, Moscow, Russia - MD Medical Group Investments PLC ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG) Russia's leading provider of private women's and children's health care, announces that in accordance with the authority granted by its shareholders at the Company's Annual General Meeting on 23 May 2014, it purchased 21,855 of its Global Depositary Receipts ("GDRs") through Deutsche Bank AG during the period 01 July 2014 through and including 04 July 2014.

The highest and lowest price paid for the purchased GDRs was US$ 9.600 and US$ 9.450 per GDR, respectively.

The purchased GDRs will be held in treasury and are expected to be used in satisfying awards made under the Long-Term Management Incentive Plan announced on 24 April 2014. Following the purchase of GDRs referred to above the Company holds a total of 39,679 GDRs as treasury GDRs and has 75,085,331 Shares in issue (excluding those GDRs held as treasury GDRs).

For further information please contact:

Investors

Media

Elena Romanova

MD Medical Group Investments PlcTel: +7 495 331 4120e.romanova@mcclinics.ru

EMMoscowTom Blackwell / Sergii PershynTel: +7 495 363 2849MDMG@em-comms.com

Consilium Strategic CommunicationsLondonEmma Thompson / Matthew NealTel: +44 20 7309 5700MDMG@em-comms.com

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 17 modern healthcare facilities, including 2 hospitals and 15 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk and Yaroslavl. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.

The Company's main medical facilities are the Perinatal Medical Center (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino hospital, a 182-bed medical centre, which opened at the end of 2012. In 2013, there were 3,816 deliveries in PMC and Lapino. The number of outpatient treatments for 2013 in PMC and the Company's outpatient clinics totalled 627,247. In March 2013, the Company began construction of its third hospital in Ufa. In April 2013 MD Medical Group completed the acquisition of the IDK Medical Company ("IDK"), a network of women's and children's health clinics located in the Russian region of Samara. In May 2013, the Company acquired Mother&Child clinic in Irkutsk, which had previously operated through a franchise agreement with MD Medical Group. The same month the Company completed a large-scale modernisation project of its Mother & Child Health Clinic in Moscow. In December 2013, a new outpatient clinic was opened in Yaroslavl which became the first healthcare facility in the region to provide IVF services.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects," "believes," "anticipates," "plans," "may," "will," "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises or guarantees, and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSEAEXXELSLEFF
Date   Source Headline
4th Oct 20218:00 amRNSMDMG OPENS A NEW ONCOLOGICAL CARE CENTRE
24th Sep 20214:41 pmRNSSecond Price Monitoring Extn
24th Sep 20214:35 pmRNSPrice Monitoring Extension
19th Aug 20214:40 pmRNSSecond Price Monitoring Extn
19th Aug 20214:35 pmRNSPrice Monitoring Extension
17th Aug 20219:00 amRNSEndovascular heart surgery on a newborn at MDMG
30th Jul 20214:36 pmRNSPrice Monitoring Extension
29th Jul 20218:00 amRNSMDMG REPORTS 51% GROWTH IN REVENUE IN H1 2021
1st Jul 20214:41 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jun 20218:00 amRNSFIRST OPEN-HEART SURGERY IN MDMG LAPINO HOSPITAL
29th Apr 20218:00 amRNSMDMG POSTS 40% REVENUE GROWTH IN Q1 2021
23rd Apr 20218:00 amRNSRESULTS OF THE AGM OF SHAREHOLDERS
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
22nd Mar 20213:15 pmRNSPUBLICATION OF 2020 ANNUAL REPORT
22nd Mar 20217:30 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
22nd Mar 20217:00 amRNSMDMG POSTS 30% EBITDA AND 56% NET PROFIT GROWTH
16th Mar 20217:00 amRNSMDMG TO ANNOUNCE FY 2020 IFRS FINANCIAL RESULTS
8th Feb 20217:00 amRNSMDMG POSTS 18% REVENUE GROWTH IN FY 2020
1st Feb 20217:00 amRNSMD MEDICAL GROUP ANNOUNCES THE LAUNCH OF LAPINO-4
29th Dec 20208:00 amRNSMDMG ANNOUNCES START OF CONSTRUCTION OF LAPINO-4
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20205:15 pmRNSCORRECTION TO MDMG ANNOUNCEMENT
10th Nov 20201:00 pmRNSMD MEDICAL GROUP ANNOUNCEMENT
9th Nov 20208:00 amRNSMDMG ANNOUNCES START OF TRADING ON MOEX
9th Nov 20207:00 amRNSMDMG POSTS SUSTAINABLE RESULTS AND REVENUE GROWTH
5th Nov 20205:45 pmRNSMDMG ANNOUNCES LISTING ON THE MOSCOW EXCHANGE
2nd Nov 20207:10 amRNSMDMG SUBMITS APPLICATION TO MOSCOW EXCHANGE
17th Sep 202012:30 pmRNSMD MEDICAL GROUP OPENS NEW SURGERY CENTRE LAPINO-2
9th Sep 202010:00 amRNSINFORMATION ON DIVIDEND PAYMENT FOR H1 2020
7th Sep 20208:00 amRNSMDMG POSTS 2% REVENUE GROWTH, 6% EBITDA GROWTH
7th Sep 20207:30 amRNSMDMG TO ANNOUNCE H1 2020 IFRS RESULTS (CORRECTION)
4th Sep 20209:42 amRNSRESULTS OF THE EXTRAORDINARY GENERAL MEETING
1st Sep 202010:00 amRNSMDMG TO ANNOUNCE H1 2020 IFRS FINANCIAL RESULTS
12th Aug 20208:00 amRNSMDMG Announcement of Extraordinary General Meeting
31st Jul 20208:00 amRNSMDMG reports H1 2020 operational results
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:35 pmRNSPrice Monitoring Extension
30th Apr 202012:07 pmRNSSecond Price Monitoring Extn
30th Apr 202012:02 pmRNSPrice Monitoring Extension
30th Apr 20208:00 amRNSMD Medical Group Increases Revenue by 7% in Q12020
24th Apr 20208:00 amRNSResults of the AGM of shareholders
14th Apr 20208:00 amRNSANNOUNCEMENT TO SHAREHOLDERS
26th Mar 20207:00 amRNSLAPINO STARTS TREATMENT OF PATIENTS WITH PNEUMONIA
23rd Mar 202010:10 amRNSPUBLICATION OF 2019 ANNUAL REPORT
23rd Mar 20207:15 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
23rd Mar 20207:00 amRNSMDMG POSTS 10% EBITDA GROWTH IN FY 2019
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.